Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region

Figure 2

EphA7 receptor was detected in benign skin disease (pilocytoma) (a) and compound nevus (b); magnification, 200x.

(a)

(b)